Cargando…
Glial Cell Line-derived Neurotrophic Factor-overexpressing Human Neural Stem/Progenitor Cells Enhance Therapeutic Efficiency in Rat with Traumatic Spinal Cord Injury
Spinal cord injury (SCI) causes axonal damage and demyelination, neural cell death, and comprehensive tissue loss, resulting in devastating neurological dysfunction. Neural stem/progenitor cell (NSPCs) transplantation provides therapeutic benefits for neural repair in SCI, and glial cell line-derive...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society for Brain and Neural Sciences
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946112/ https://www.ncbi.nlm.nih.gov/pubmed/31902156 http://dx.doi.org/10.5607/en.2019.28.6.679 |
_version_ | 1783485291876581376 |
---|---|
author | Hwang, Kyujin Jung, Kwangsoo Kim, Il-Sun Kim, Miri Han, Jungho Lim, Joohee Shin, Jeong Eun Jang, Jae-Hyung Park, Kook In |
author_facet | Hwang, Kyujin Jung, Kwangsoo Kim, Il-Sun Kim, Miri Han, Jungho Lim, Joohee Shin, Jeong Eun Jang, Jae-Hyung Park, Kook In |
author_sort | Hwang, Kyujin |
collection | PubMed |
description | Spinal cord injury (SCI) causes axonal damage and demyelination, neural cell death, and comprehensive tissue loss, resulting in devastating neurological dysfunction. Neural stem/progenitor cell (NSPCs) transplantation provides therapeutic benefits for neural repair in SCI, and glial cell line-derived neurotrophic factor (GDNF) has been uncovered to have capability of stimulating axonal regeneration and remyelination after SCI. In this study, to evaluate whether GDNF would augment therapeutic effects of NSPCs for SCI, GDNF-encoding or mock adenoviral vector-transduced human NSPCs (GDNF-or Mock-hNSPCs) were transplanted into the injured thoracic spinal cords of rats at 7 days after SCI. Grafted GDNF-hNSPCs showed robust engraftment, long-term survival, an extensive distribution, and increased differentiation into neurons and oligodendroglial cells. Compared with Mock-hNSPC- and vehicle-injected groups, transplantation of GDNF-hNSPCs significantly reduced lesion volume and glial scar formation, promoted neurite outgrowth, axonal regeneration and myelination, increased Schwann cell migration that contributed to the myelin repair, and improved locomotor recovery. In addition, tract tracing demonstrated that transplantation of GDNF-hNSPCs reduced significantly axonal dieback of the dorsal corticospinal tract (dCST), and increased the levels of dCST collaterals, propriospinal neurons (PSNs), and contacts between dCST collaterals and PSNs in the cervical enlargement over that of the controls. Finally grafted GDNF-hNSPCs substantially reversed the increased expression of voltage-gated sodium channels and neuropeptide Y, and elevated expression of GABA in the injured spinal cord, which are involved in the attenuation of neuropathic pain after SCI. These findings suggest that implantation of GDNF-hNSPCs enhances therapeutic efficiency of hNSPCs-based cell therapy for SCI. |
format | Online Article Text |
id | pubmed-6946112 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | The Korean Society for Brain and Neural Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-69461122020-01-15 Glial Cell Line-derived Neurotrophic Factor-overexpressing Human Neural Stem/Progenitor Cells Enhance Therapeutic Efficiency in Rat with Traumatic Spinal Cord Injury Hwang, Kyujin Jung, Kwangsoo Kim, Il-Sun Kim, Miri Han, Jungho Lim, Joohee Shin, Jeong Eun Jang, Jae-Hyung Park, Kook In Exp Neurobiol Original Article Spinal cord injury (SCI) causes axonal damage and demyelination, neural cell death, and comprehensive tissue loss, resulting in devastating neurological dysfunction. Neural stem/progenitor cell (NSPCs) transplantation provides therapeutic benefits for neural repair in SCI, and glial cell line-derived neurotrophic factor (GDNF) has been uncovered to have capability of stimulating axonal regeneration and remyelination after SCI. In this study, to evaluate whether GDNF would augment therapeutic effects of NSPCs for SCI, GDNF-encoding or mock adenoviral vector-transduced human NSPCs (GDNF-or Mock-hNSPCs) were transplanted into the injured thoracic spinal cords of rats at 7 days after SCI. Grafted GDNF-hNSPCs showed robust engraftment, long-term survival, an extensive distribution, and increased differentiation into neurons and oligodendroglial cells. Compared with Mock-hNSPC- and vehicle-injected groups, transplantation of GDNF-hNSPCs significantly reduced lesion volume and glial scar formation, promoted neurite outgrowth, axonal regeneration and myelination, increased Schwann cell migration that contributed to the myelin repair, and improved locomotor recovery. In addition, tract tracing demonstrated that transplantation of GDNF-hNSPCs reduced significantly axonal dieback of the dorsal corticospinal tract (dCST), and increased the levels of dCST collaterals, propriospinal neurons (PSNs), and contacts between dCST collaterals and PSNs in the cervical enlargement over that of the controls. Finally grafted GDNF-hNSPCs substantially reversed the increased expression of voltage-gated sodium channels and neuropeptide Y, and elevated expression of GABA in the injured spinal cord, which are involved in the attenuation of neuropathic pain after SCI. These findings suggest that implantation of GDNF-hNSPCs enhances therapeutic efficiency of hNSPCs-based cell therapy for SCI. The Korean Society for Brain and Neural Sciences 2019-12 2019-12-31 /pmc/articles/PMC6946112/ /pubmed/31902156 http://dx.doi.org/10.5607/en.2019.28.6.679 Text en Copyright © Experimental Neurobiology 2019 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Hwang, Kyujin Jung, Kwangsoo Kim, Il-Sun Kim, Miri Han, Jungho Lim, Joohee Shin, Jeong Eun Jang, Jae-Hyung Park, Kook In Glial Cell Line-derived Neurotrophic Factor-overexpressing Human Neural Stem/Progenitor Cells Enhance Therapeutic Efficiency in Rat with Traumatic Spinal Cord Injury |
title | Glial Cell Line-derived Neurotrophic Factor-overexpressing Human Neural Stem/Progenitor Cells Enhance Therapeutic Efficiency in Rat with Traumatic Spinal Cord Injury |
title_full | Glial Cell Line-derived Neurotrophic Factor-overexpressing Human Neural Stem/Progenitor Cells Enhance Therapeutic Efficiency in Rat with Traumatic Spinal Cord Injury |
title_fullStr | Glial Cell Line-derived Neurotrophic Factor-overexpressing Human Neural Stem/Progenitor Cells Enhance Therapeutic Efficiency in Rat with Traumatic Spinal Cord Injury |
title_full_unstemmed | Glial Cell Line-derived Neurotrophic Factor-overexpressing Human Neural Stem/Progenitor Cells Enhance Therapeutic Efficiency in Rat with Traumatic Spinal Cord Injury |
title_short | Glial Cell Line-derived Neurotrophic Factor-overexpressing Human Neural Stem/Progenitor Cells Enhance Therapeutic Efficiency in Rat with Traumatic Spinal Cord Injury |
title_sort | glial cell line-derived neurotrophic factor-overexpressing human neural stem/progenitor cells enhance therapeutic efficiency in rat with traumatic spinal cord injury |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946112/ https://www.ncbi.nlm.nih.gov/pubmed/31902156 http://dx.doi.org/10.5607/en.2019.28.6.679 |
work_keys_str_mv | AT hwangkyujin glialcelllinederivedneurotrophicfactoroverexpressinghumanneuralstemprogenitorcellsenhancetherapeuticefficiencyinratwithtraumaticspinalcordinjury AT jungkwangsoo glialcelllinederivedneurotrophicfactoroverexpressinghumanneuralstemprogenitorcellsenhancetherapeuticefficiencyinratwithtraumaticspinalcordinjury AT kimilsun glialcelllinederivedneurotrophicfactoroverexpressinghumanneuralstemprogenitorcellsenhancetherapeuticefficiencyinratwithtraumaticspinalcordinjury AT kimmiri glialcelllinederivedneurotrophicfactoroverexpressinghumanneuralstemprogenitorcellsenhancetherapeuticefficiencyinratwithtraumaticspinalcordinjury AT hanjungho glialcelllinederivedneurotrophicfactoroverexpressinghumanneuralstemprogenitorcellsenhancetherapeuticefficiencyinratwithtraumaticspinalcordinjury AT limjoohee glialcelllinederivedneurotrophicfactoroverexpressinghumanneuralstemprogenitorcellsenhancetherapeuticefficiencyinratwithtraumaticspinalcordinjury AT shinjeongeun glialcelllinederivedneurotrophicfactoroverexpressinghumanneuralstemprogenitorcellsenhancetherapeuticefficiencyinratwithtraumaticspinalcordinjury AT jangjaehyung glialcelllinederivedneurotrophicfactoroverexpressinghumanneuralstemprogenitorcellsenhancetherapeuticefficiencyinratwithtraumaticspinalcordinjury AT parkkookin glialcelllinederivedneurotrophicfactoroverexpressinghumanneuralstemprogenitorcellsenhancetherapeuticefficiencyinratwithtraumaticspinalcordinjury |